Tirzepatide Clinics in Pennsylvania
Compare Tirzepatide providers in Pennsylvania. Check ratings, telehealth availability, and insurance acceptance to find the right prescriber.
Cities With Tirzepatide Providers in Pennsylvania
All Tirzepatide Clinics in Pennsylvania
Dr. Robert Fortino's Medical Weight Loss Center Philadelphia
Dr. Charlie Seltzer Lifestyle Medicine
MD Weight Loss & Beyond
WellZone Medical Weight Loss
PhillyMedClub
Options Medical Weight Loss Clinic
New You Weight Loss & Aesthetics
Medi-Weightloss Berwyn
Options Medical Weight Loss
Azani Medical Spa
Enigma Plastic Surgery
Elevation Medical Weight Loss Green Tree
Elevation Medical Weight Loss Shadyside
Tried and True Weightloss
Gentle Beauty Solutions
Aspire Rejuvenation Clinic - Pittsburgh
Avere Beauty
Aetheria Aesthetics & Wellness
fillir
The Hormone Center
Yofi Aesthetics
Lips and Drips by Erica Marie LLC
Viva Care Solutions
Bucky Body Center
Revive Medical
OnPoint Nutrition
Infinity Health and Wellness
Jovial Med Spa
Look Great MD
The Natural Xpression
Revive Medical Weight Loss and Wellness
Penn Medical Group
About Tirzepatide in Pennsylvania
What is Tirzepatide?
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist developed by Eli Lilly. It uniquely targets both the GIP and GLP-1 receptors, producing greater weight loss and blood sugar control than GLP-1-only medications. Approved as Mounjaro for type 2 diabetes (2022) and Zepbound for weight management (2023), tirzepatide has shown weight loss of up to 22.5% in clinical trials — the highest of any GLP-1 class medication.
Brand Names
Tirzepatide is available as Mounjaro, Zepbound, manufactured by Eli Lilly.
Expected Weight Loss
In the SURMOUNT-1 trial, participants on tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks. At the 10 mg dose, average weight loss was 21.4%. Over a third (36%) on the highest dose lost 25% or more of their body weight, and 63% lost 20% or more.
Cost in Pennsylvania
Without insurance, Tirzepatide typically costs $1,000-$1,200/month (Mounjaro), $1,000-$1,100/month (Zepbound). With insurance, costs range from $25-$200/month (varies by plan). Compounded options may be available at $250-$550/month.
Savings programs: Eli Lilly offers the Zepbound Savings Card (commercially insured patients may pay as low as $25/month) and the LillyDirect platform for direct-to-patient delivery.
Frequently Asked Questions
There are 33 clinics prescribing Tirzepatide (Mounjaro and Zepbound) in Pennsylvania. Pennsylvania is one of the better-served states for Tirzepatide availability.
Yes, 20 of 33 Tirzepatide providers in Pennsylvania (61%) offer telehealth. Most providers here support virtual visits, so you can start treatment without an office visit.
Brand-name Mounjaro and Zepbound costs $800–$1,400/month without insurance in Pennsylvania. Compounded Tirzepatide from clinic weight loss programs typically runs $200–$500/month. With insurance, copays range from $25–$200/month depending on your plan's formulary and whether prior authorization is required.
Yes. Tirzepatide is a prescription medication in all US states including Pennsylvania. You can get evaluated and prescribed through 20 telehealth providers in Pennsylvania, or visit any of the 33 clinics listed here in person.
Coverage depends on your plan and diagnosis. Tirzepatide is widely covered for type 2 diabetes. For weight management, coverage is expanding — Wegovy and Zepbound now have broader approval, but many plans still require prior authorization or documented BMI criteria. Check with your insurer or ask the clinic to verify coverage before your appointment.
Related Articles
Zepbound vs Mounjaro: Understanding Tirzepatide Options
Zepbound and Mounjaro both contain tirzepatide but are approved for different conditions. Compare their dosing, cost, and insurance coverage.
costHow Much Does Mounjaro Cost Without Insurance in 2026?
Mounjaro's list price, savings programs, and what you can expect to pay out of pocket. Updated pricing for 2026.
medicationsGLP-1 Medications for Type 2 Diabetes vs Weight Loss: Key Differences
GLP-1 drugs treat both type 2 diabetes and obesity, but dosing, insurance coverage, and FDA approvals differ significantly between the two uses.